After completing the main construction phase of Wendelstein 7-X (W7-X) and successfully commissioning the device, first plasma operation started at the end of 2015. Integral commissioning of plasma start-up and operation using electron cyclotron resonance heating (ECRH) and an extensive set of plasma diagnostics have been completed, allowing initial physics studies during the first operational campaign. Both in helium and hydrogen, plasma breakdown was easily achieved. Gaining experience with plasma vessel conditioning, discharge lengths could be extended gradually. Eventually, discharges lasted up to 6 s, reaching an injected energy of 4 MJ, which is twice the limit originally agreed for the limiter configuration employed during the first operational campaign. At power levels of 4 MW central electron densities reached 3 × 1019 m−3, central electron temperatures reached values of 7 keV and ion temperatures reached just above 2 keV. Important physics studies during this first operational phase include a first assessment of power balance and energy confinement, ECRH power deposition experiments, 2nd harmonic O-mode ECRH using multi-pass absorption, and current drive experiments using electron cyclotron current drive. As in many plasma discharges the electron temperature exceeds the ion temperature significantly, these plasmas are governed by core electron root confinement showing a strong positive electric field in the plasma centre.
Table of contentsP001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP effluxR. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. EllisP002 - Lower serum immunoglobulin G2 level does not predispose to severe flu.J. Solé-Violán, M. López-Rodríguez, E. Herrera-Ramos, J. Ruíz-Hernández, L. Borderías, J. Horcajada, N. González-Quevedo, O. Rajas, M. Briones, F. Rodríguez de Castro, C. Rodríguez GallegoP003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsisF. Esen, G. Orhun, P. Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. TuzunP004 - Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopeniaR. Riff, O. Naamani, A. DouvdevaniP005 - Analysis of neutrophil by hyper spectral imaging - A preliminary reportR. Takegawa, H. Yoshida, T. Hirose, N. Yamamoto, H. Hagiya, M. Ojima, Y. Akeda, O. Tasaki, K. Tomono, T. ShimazuP006 - Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgeryS. Ono, T. Kubo, S. Suda, T. Ueno, T. IkedaP007 - Serial change of c1 inhibitor in patients with sepsis – A prospective observational studyT. Hirose, H. Ogura, H. Takahashi, M. Ojima, J. Kang, Y. Nakamura, T. Kojima, T. ShimazuP008 - Comparison of bacteremia and sepsis on sepsis related biomarkersT. Ikeda, S. Suda, Y. Izutani, T. Ueno, S. OnoP009 - The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purificationT. Taniguchi, M. OP010 - Validation of a new sensitive point of care device for rapid measurement of procalcitoninC. Dinter, J. Lotz, B. Eilers, C. Wissmann, R. LottP011 - Infection biomarkers in primary care patients with acute respiratory tract infections – Comparison of procalcitonin and C-reactive proteinM. M. Meili, P. S. SchuetzP012 - Do we need a lower procalcitonin cut off?H. Hawa, M. Sharshir, M. Aburageila, N. SalahuddinP013 - The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteriaV. Chantziara, S. Georgiou, A. Tsimogianni, P. Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, G. Micha, E. Chinou, G. MichaloudisP014 - Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiberA. Kodaira, T. Ikeda, S. Ono, T. Ueno, S. Suda, Y. Izutani, H. ImaizumiP015 - Diagnostic usefullness of combination biomarkers on ICU admissionM. V. De la Torre-Prados, A. Garcia-De la Torre, A. Enguix-Armada, A. Puerto-Morlan, V. Perez-Valero, A. Garcia-AlcantaraP016 - Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patientsN. Bolton, J. Dudziak, S. Bonney, A. Tridente, P. NeeP017 - Extracellular histone H3 levels are in...
The spectral emission of atoms in a dusty radio frequence (rf) discharge plasma in argon and helium has been measured with a gated ICCD camera. The spatially and temporally resolved emission/excitation of the argon and helium atoms during the rf cycle in the dusty discharge was compared to the dust-free case. In the bulk plasma above the dust cloud, the emission is clearly enhanced in the dusty discharge with respect to the pure discharge, whereas in the sheath the emission is reduced. In addition, the emission of a dusty argon plasma is studied via particle-particle particle-mesh (P³M) simulations. The rf dynamics with a single dust particle trapped in the sheath was calculated. Like in the experiment the dust modifies the atomic emission. The spatiotemporal excitation pattern of the experiment is reproduced and a detailed understanding of the difference in excitation of the discharge with and without dust is presented.
In this paper a review of the work on particle simulations of dusty plasmas using a three-dimensional Particle-Particle Particle-Mesh (P 3 M) code is presented. The code is applied to study the charging process of micrometre size dust grains confined in low temperature plasmas. This code gives a full-scale selfconsistent kinetic description of both the background plasma and the charging of the dust particle. Particles (electrons and ions) are treated kinetically (Particlein-Cell with Monte Carlo Collisions (PIC-MCC)), which allows us to selfconsistently resolve the electrostatic sheath in front of the material wall. In order to accurately resolve the plasma particles' motion close to the dust grain, the PIC technique is supplemented with molecular dynamics (MD), employing the Coulomb potential for the interaction with the dust grain. The plasma particle trajectories are accurately followed in the close vicinity of the dust grain and by this finite-size effects for dust grains are included. Dust grain charging due to absorption of plasma particles and ion drag forces arising from momentum transfer of flowing ions to dust grains are studied.
Sander lucioperca is an organism of growing importance for the aquaculture industry.Nonetheless, the rearing of S. lucioperca larvae is proving to be a difficult task as it is facing a high mortality rate during hatching and the change to exogenous feeding. To gain insight into growth patterns during this period, the authors analysed pikeperch embryos and larvae from 9 days before hatching to 17 days after hatch. Hereby they were able to describe a natural development by using close to natural conditions based on using a direct flow-through supply of lake fresh water on specimens from a local wild population. The results show that between the early embryonic stages a steady growth was visible. Nonetheless, in between hatching and the start of exogenous feeding, a phase of growth stagnation took place. In the following larval stages, an increased growth with large size variations between individual specimens appeared. Both factors are conspicuous as they can indicate a starting point for cannibalism. With this analysis, the authors can provide a fundament to support the upcoming research on S. lucioperca and aid to optimize size-sorting procedures for a higher survival of pikeperch stock in aquaculture.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.